Mira Pharmaceuticals MIRA
NASDAQ MIRA
$0.62 -0.01 (-1.59%)
At close: Oct 23, 2026 · 4:00 PM EDT

Mira Pharmaceuticals (MIRA) Selling, General & Administrative (2022 - 2025)

Updated

Mira Pharmaceuticals (MIRA) posted Selling, General & Administrative of $5.33 million for the quarter ended Dec 31, 2025, up 238.0% from $1.58 million a year earlier and up 489.2% from the prior quarter.

Analysis

Mira Pharmaceuticals (MIRA) Selling, General & Administrative (2022 - 2025) Analysis & Trends

For the year ended Dec 31, 2025, Mira Pharmaceuticals' Selling, General & Administrative came in at $8.77 million, up 86.2% from the prior year.

  • Annual Selling, General & Administrative shows a three-year compound annual growth rate of 43.1% (years ended Dec 2022 to Dec 2025).
  • In prior years, Mira Pharmaceuticals' Selling, General & Administrative was $4.71 million in the year ended Dec 31, 2024 (-27.5%), $6.5 million in the year ended Dec 31, 2023 (+117.2%) and $2.99 million in the year ended Dec 31, 2022.
  • The figure for the quarter ended Dec 31, 2025 stands as the highest quarterly Selling, General & Administrative in data going back to the quarter ended Sep 30, 2022.
  • On a year-over-year basis, Selling, General & Administrative increased in four of the last eight quarters, with growth averaging 30.5%.
  • The strongest year-over-year quarter for Selling, General & Administrative in the past five years was the quarter ended Dec 31, 2025, with growth of 238.0%; the weakest was the quarter ended Sep 30, 2024, with a decline of 52.7%.
  • According to Business Quant data, Selling, General & Administrative for the three prior quarters was $904,346 (quarter ended Sep 30, 2025), $1.05 million (quarter ended Jun 30, 2025) and $1.49 million (quarter ended Mar 31, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 6.29 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 3.63 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 3.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 5.65 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.92 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 3.41 Bn
10 Mira Pharmaceuticals 14.69 Mn -5.81 Mn - 5.33 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 5.33 Mn
Sep 30, 2025 904,346.00
Jun 30, 2025 1.05 Mn
Mar 31, 2025 1.49 Mn
Dec 31, 2024 1.58 Mn
Sep 30, 2024 1.01 Mn
Jun 30, 2024 1.12 Mn
Mar 31, 2024 1.01 Mn
Dec 31, 2023 2.67 Mn
Sep 30, 2023 2.14 Mn
Jun 30, 2023 1.07 Mn
Mar 31, 2023 614,235.00
Dec 31, 2022 51,656.00
Sep 30, 2022 736,059.00
Jun 30, 2022 1.59 Mn
API Access

Mira Pharmaceuticals Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=MIRA&period=max&api_key=YOUR_API_KEY